-
Tempus AI is at the forefront of developing advanced artificial intelligence technologies designed to enhance patient outcomes across multiple areas of healthcare.
-
Recently, Ark Invest has decided to decrease its exposure to Tempus AI within the ARK Innovation ETF.
-
However, Tempus AI maintains a strong presence, with a significant allocation in the ARK Genomic Revolution ETF.
Invest in Gold
This week, Tempus AI (NASDAQ: TEM) experienced a notable 161% increase in stock value since the beginning of the year, showcasing its impressive advancements in artificial intelligence tailored to improve healthcare outcomes. However, a recent market response highlighted a decision from a prominent investor to reduce her holdings in Tempus AI stock, leading to a sharp decline.
As reported by S&P Global Market Intelligence, Tempus AI’s shares dropped by 12.4% between last Friday and the close of Thursday’s trading session.
Tempus AI has been a key player in various Ark Invest exchange-traded funds (ETFs) and has seen a reduction in its weighting within the ARK Innovation ETF (NYSEMKT: ARKK). Earlier this week, Ark Invest sold off 62,352 shares of Tempus AI stock, translating to approximately $5.2 million.
This decision came shortly after Tempus AI announced it secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its RNA-based Tempus xR IVD device, a critical tool aimed at enhancing drug development initiatives.
Despite the drawdown in the ARK Innovation ETF, it’s noteworthy that Tempus AI still holds the top spot in the ARK Genomic Revolution ETF, maintaining a 10.7% weighting as of Thursday’s market close.
While the reduction of Ark Invest’s holdings may concern some investors, Tempus AI’s continued prominence in another major ETF suggests that Cathie Wood remains confident in the stock’s potential. Ark Invest’s strategy often involves buying and selling stocks periodically, indicating that a potential rebound in interest for Tempus AI could occur if the stock price continues to decline.
If you were optimistic about Tempus AI yesterday, remember that this news alone shouldn’t deter your investment thesis.
However, before considering an investment in Tempus AI, take note of this:
The Motley Fool Stock Advisor analyst team has recently uncovered what they believe to be the 10 best stocks for investment right now… and Tempus AI did not make the cut. The selected stocks have the potential to yield substantial returns in the foreseeable future.
